Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSurvival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours
Sarcoma, 06/16/09
Porter DE et al. - After multivariate analysis, however, only NF1 and tumour volume more than 200 m remained independent predictors of poor outcome. The authors recommend that NF1 be taken into account during MPNST staging.
Related Articles
Malignant Peripheral Nerve Sheath Tumor of the Renal Pelvis
Urologia Internationalis, 10/22/09
Relevance Score: 85%
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
Neuro-Oncology, 10/06/09
Relevance Score: 84%
Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis
Oncogene, 11/12/09
Relevance Score: 80%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Cancer Research, 12/20/09
Acyl-CoA Synthetase VL3 Knockdown Inhibits Human Glioma Cell Proliferation and Tumorigenicity
Cancer Research, 12/20/09
Mutant Metabolic Enzymes Are at the Origin of Gliomas
Cancer Research, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor